Clinical Trials at Carlisle Regional Cancer Center
As of September 2026, 15 paid clinical trials are recruiting at Carlisle Regional Cancer Center, located at UPMC Hillman Cancer Center (Radiation Oncology), 25 Sprint Dr, Carlisle, PA 17015, phone (717) 960-3746 in Carlisle, Pennsylvania. Active studies at this site cover conditions such as Breast Cancer, Lung Non-Small Cell Carcinoma and Prostate Adenocarcinoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
15 clinical trials at Carlisle Regional Cancer Center
·Clear filters·Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
E-Mindfulness Approaches for Living After Breast Cancer
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Common conditions studied in Carlisle
- Breast Cancer (2 active studies)
- Lung Non-Small Cell Carcinoma (2 active studies)
- Prostate Adenocarcinoma (2 active studies)
- Anatomic Stage I Breast Cancer AJCC v8 (1 active study)
- Anatomic Stage II Breast Cancer AJCC v8 (1 active study)
- Biochemically Recurrent Prostate Carcinoma (1 active study)
Leading research sponsors in Carlisle
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- ECOG-ACRIN Cancer Research Group
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Carlisle?
There are approximately 15 recruiting clinical trials in Carlisle, Pennsylvania listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Carlisle pay participants?
Most recruiting trials in Carlisle compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Carlisle?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Carlisle?
The most common conditions under active study in Carlisle include Breast Cancer (2), Lung Non-Small Cell Carcinoma (2), Prostate Adenocarcinoma (2), Anatomic Stage I Breast Cancer AJCC v8 (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Carlisle?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Carlisle on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Carlisle?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Carlisle?
Recruiting research sites in Carlisle include Carlisle Regional Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Carlisle right now?
The largest active categories in Carlisle are Cancer & tumors (15), Mental health & behavior (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Carlisle Regional Cancer Center?
Carlisle Regional Cancer Center is located at UPMC Hillman Cancer Center (Radiation Oncology), 25 Sprint Dr, Carlisle, PA 17015. Use the Google Maps link in the intro above to get directions.
How do I contact Carlisle Regional Cancer Center?
You can reach Carlisle Regional Cancer Center by phone at (717) 960-3746. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.